Breast Cancer Awareness Month: Support, Not Selling

This Post Isn't Selling Anything

Every October, wellness brands turn pink. Desert Harvest is choosing a different lane this year: this post carries no product, no collection, and no offer. It exists because breast cancer touches nearly every reader on our list, and because the numbers, the screening guidance, and the menopause-specific pieces of this conversation are worth having in one place.

Start with scale. According to the National Cancer Institute's SEER program, approximately 13.0 percent of women will be diagnosed with female breast cancer at some point during their lifetime, based on 2021–2023 data — roughly one in eight women you know.

Stage at diagnosis matters enormously to outcomes. SEER's own figures show 64% of cases are found at the localized stage, where 5-year relative survival is 100.0%. Across every stage combined, 5-year relative survival is 91.9%. Those numbers are not distributed evenly, either: non-Hispanic Black women carry the highest breast cancer death rate of any group in the United States, a gap worth naming plainly in a post that means to be useful rather than performative. All of it is why the next section matters.

What Screening Guidance Actually Says

In 2024, the U.S. Preventive Services Task Force updated its guidance. In its own words: "The Task Force now recommends that all women get screened every other year starting at age 40." The full recommendation statement, published in JAMA, concludes with moderate certainty that biennial mammography for women aged 40 to 74 carries a moderate net benefit.

That is general guidance for women at average risk — and averages don't describe any one person. Dense breast tissue, a family history of breast or ovarian cancer, and inherited gene changes all shift the calculus; the Task Force itself says the evidence is still insufficient to know whether supplemental ultrasound or MRI helps women with dense breasts. The National Cancer Institute keeps a plain-language mammogram fact sheet for exactly this reason. None of it replaces a direct conversation with your own provider about your own risk and your own timing.

Where Menopause and Breast Cancer Intersect

Our readers are disproportionately in or near the menopause transition, so two overlaps deserve naming directly. The first is hormone therapy. Whether menopausal hormone therapy changes breast cancer risk, and by how much, is genuinely a conversation for your provider — shaped by your personal and family history, the type and duration of therapy, and evolving FDA labeling. We covered the FDA's decision to remove the boxed warning from menopausal hormone therapy in an earlier post; read it alongside whatever your own doctor tells you, never instead of it.

The second overlap gets talked about less: women who have completed breast cancer care often carry menopause-like symptoms afterward, sometimes suddenly and at a younger age than expected. A peer-reviewed update on genitourinary syndrome of menopause in breast cancer survivors notes that systemic estrogen therapy is typically off the table for these women, so care teams lean on non-hormonal moisturizers, lubricants, and other options first. The Menopause Society maintains its own patient guidance on menopause symptoms, and survivorship care for exactly this group is a growing part of it.

A Community That Reminds Each Other

If you spend time in bladder-health or menopause communities, you already know the habit: someone posts "just booked my mammogram, who's due for theirs?" and three more people schedule the same week. That kind of nudge is often what actually gets the appointment on the calendar. We've written before about the early signs of perimenopause in your late 30s and 40s, the practical differences between perimenopause and menopause, and the menopause symptom almost nobody names out loud. None of those posts mention breast cancer, but they come from the same instinct as this one: name the thing plainly, then point you toward someone qualified to help.

Consider this your nudge. If you are 40 or older, or younger with a family history worth raising, ask your provider when your next mammogram is due and put it on the calendar this week — not "eventually."

Resources Worth Bookmarking

The National Cancer Institute (cancer.gov) publishes plain-language fact sheets on mammograms and on personal risk factors, written for patients rather than clinicians. The American Cancer Society (cancer.org) keeps detailed, regularly updated guides on breast cancer screening and diagnosis. The Office on Women's Health is a good starting point if you want the short version before a longer read.

Screening finds cancers earlier than symptoms usually do, and earlier-stage disease carries a very different 5-year relative survival than disease found late, per SEER's own numbers above. That isn't a promise about any one person's outcome — it's simply what the data shows at a population level, and it's the reason the appointment is worth making this month, not "eventually."

Please talk with a qualified healthcare provider about your personal risk factors and the screening schedule that's right for you; national guidance is a starting point, never a substitute for that conversation.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making changes to your health regimen.